Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis, an Ultra-Rare Disease

Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical company, and Innovative Molecules GmbH ("Innovative Molecules"), a ...

Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis,

Adibelivir is a next generation helicase-primase inhibitor. The oral formulation is advancing toward Phase 2 development for genital herpes, while the parenteral formulation is dedicated exclusively ...

NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave – NV-387 is Effective Against H3N2

SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Le Lézard

The Walt Disney Company Executives to Discuss Fiscal First Quarter 2026 Financial Results via Webcast

The Walt Disney Company will host a live audio webcast to discuss fiscal first quarter 2026 financial results beginning at 8:30 a.m. ET / 5:30 a.m. PT on Monday, February 2, 2026. Disney will release ...
Le Lézard

MTF Biologics and Kolosis BIO Launch New Solution for Orthopedic and Spinal Surgeries: Summit Matrixtm

MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, ...
Arizona Daily Star

Ore. woman wins $900K in herpes lawsuit

PORTLAND, Ore. — An Oregon jury has awarded $900,000 to a 49-year-old woman who claimed that a 69-year-old Portland man intentionally gave her a sexually transmitted disease after they met on an ...